What You Should Know
The Partnership: Verily Life Sciences and Samsung Electronics America are collaborating to integrate the Samsung Galaxy Watch 8 directly into Verily’s precision health platform, Pre.The Clinical Goal: The joint solution is designed to accelerate research for life sciences and government customers by allowing them to run real-world studies using continuous, consumer-grade wearable data.The Hardware: The Galaxy Watch 8 acts as a robust clinical tool, bringing FDA-cleared
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
From Mass Messaging to N-of-1: How Agentic AI Closes the Life Sciences Trust Gap
What You Should Know
The Failure: Lirio, in partnership with healthcare consultancy Sage Growth Partners, released "From Mass Messaging to N-of-1," a survey of 75 life sciences executives. The report reveals that traditional "segment-based" personalization in life sciences is failing to move the needle. 79% of leaders cite clinical trial engagement and 72% cite medication adherence as their most persistent challenges.The Shift: The industry is pivoting from "Mass Messaging" to "N-of-1"
Read More
Mount Sinai Deploys AI-Powered Clinical Trial-Matching Platform to Expand Access to Cancer Research
What You Should Know:
- Mount Sinai Tisch Cancer Center has deployed PRISM, an AI-powered platform designed by Triomics for systemwide clinical trial matching.
- Utilizing OncoLLM—a large language model pipeline built specifically for oncology—PRISM identifies eligible patients across the entire Mount Sinai Health System (including Queens and Brooklyn) in real-time.
- The strategic initiative aims to accelerate research enrollment and provide equitable access to cutting-edge
Read More
Valinor Raises $13M to Predict Clinical Trial Outcomes Using Multi-Omic AI
What You Should Know:
- Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry's most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
- The company uses proprietary AI models trained on matched multi-omic samples and clinical outcomes to predict how specific patient populations will respond to new therapies. This "response-first" approach aims to drastically de-risk drug development by identifying responders
Read More
Accenture Invests in Ryght AI to Accelerate Clinical Trials with Agentic AI and Digital Twins
What You Should Know:
- Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes "agentic AI" and its proprietary AI Site Twin platform to create dynamic digital replicas of research sites, allowing pharmaceutical companies to optimize site selection and patient enrollment.
- The strategic collaboration seeks to remove the manual bottlenecks that delay life-saving therapies,
Read More
MRO Acquires Clinetic to Accelerate Clinical Trial Patient Recruitment with AI-Driven Data
What You Should Know:
- MRO has acquired Clinetic, a recruitment management platform, to enhance its smarter data commitment. Financial details of the acquisition were not disclosed.
- The acquisition integrates Clinetic’s AI-driven software, which leverages real-time EHR data to identify, screen, and enroll clinical trial patients faster and with greater precision.
MRO Strengthens "Smarter Data" Focus with Clinetic Acquisition
MRO, a company committed to being the single
Read More
Virtual Clinical Trials: Mayo Clinic’s AI-Powered Solution to Accelerate Heart Failure Drug Discovery
What You Should Know:
- Heart failure is a critical health issue affecting millions of Americans, and despite decades of research, effective treatment options remain limited. Traditional drug development is a slow, costly, and high-risk process.
- Researchers at Mayo Clinic are pioneering a new approach using artificial intelligence (AI) and "virtual clinical trials" to accelerate the discovery of new therapies, particularly by repurposing existing drugs.
An Urgent Need for
Read More
Inato Unveils AI Capabilities to Transform Clinical Trial Site Selection
What You Should Know:
- Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and verified data from over 5,500 sites quickly and easily.
- The new capabilities fill an acute gap for sponsor decision-makers, arming them with the insights they need to quickly and confidently choose the right mix of sites for each trial.
Inato Unveils
Read More
Proscia Launches AI Solution to Advance Precision Medicine
What You Should Know:
- Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
- The AI-powered tool aims to tackle one of healthcare’s most significant challenges: connecting patients with life-saving therapies and accelerating the development of new treatments.
Transforming Pathology Data Into Real-Time
Read More
Veeva Systems and Amgen Partner to Advance Clinical Trial Innovation
What You Should Know:
- Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
- Amgen will use the Veeva Clinical Platform to find and implement efficiencies across its clinical trial processes.
Connected Platform for Clinical Development
The Veeva Clinical Platform is a complete and connected platform that covers clinical operations and data applications. This end-to-end platform includes
Read More
